Building Your Care Team & Preparing for Your Visit
At a Glance
Euthyroid Graves orbitopathy is best managed by coordinated eye and endocrine specialists. Bring original scans, complete thyroid and antibody results, old photographs, and a symptom timeline, and continue periodic thyroid testing because hyperthyroidism can develop later.
Navigating Euthyroid Graves Orbitopathy (EGO) requires a specialized team because your case is a “rare subset of a rare disease.” While most Thyroid Eye Disease (TED) patients have an overactive thyroid, you are among the estimated 5% to 8% whose thyroid function tests are normal [1][2].
Because your condition is less common and often presents asymmetrically (affecting one eye more than the other), it is essential to build a team that looks beyond standard thyroid screens to focus on the health of your eyes and the future of your thyroid function. The emotional impact of visible eye changes, double vision, and uncertainty can be profound; a supportive care team can help you navigate this.
Building Your Core Care Team
A “multidisciplinary” approach—where different specialists talk to each other—is the gold standard for EGO care [3][4]. Your team should include:
- TED Specialist (Oculoplastic Surgeon or Neuro-ophthalmologist): These are the captains of your eye care. They focus on the orbit (the eye socket), managing inflammation, and performing restorative surgeries if needed [5][6].
- Endocrinologist: Even though your levels are normal now, you still need an endocrinologist. In specific clinical cohorts followed over time, approximately 24% of euthyroid TED patients eventually developed hyperthyroidism [7][2]. An endocrinologist will monitor your TSH and Free T4 over the long term [8][9].
- Strabismus Specialist: If you develop double vision, an ophthalmologist who specializes in the eye muscles (strabismus) may join your team to help align your eyes [10].
Vetting Your Specialist
When you meet a potential specialist, it is okay to “interview” them to ensure they have the expertise needed for EGO. You can ask:
- “How do you approach antibody testing?” A specialist familiar with EGO will know that a negative TRAb or TBII (binding test) does not rule out the disease and may use more sensitive TSI or TSAb (functional) assays to support the diagnosis when suspicion is high [11][8].
- “How do you track disease progress?” Ask if they use structured assessment tools like the VISA or EUGOGO protocols, which look at Vision, Inflammation, Strabismus, and Appearance [12][13].
- “What is your case volume?” While there is no “magic number,” you want a surgeon who regularly manages the orbital and surgical complexities of TED [14].
First Visit Checklist: What to Bring
Your first specialist visit is a high-stakes information-gathering session. To get the most out of it, you must bring the “raw data,” not just the summaries:
- Imaging on a CD/USB: Bring the actual digital images of your MRI or CT scans. Specialists often see subtle muscle changes or “tendon sparing” that a general radiologist might miss in a written report [15][16].
- Complete Lab History: Bring printed copies of all thyroid function tests (TSH, Free T4, T3) and antibody results (TSI, TRAb). A “normal” result in your chart is more useful if the specialist can see exactly where in the range you fall [1][11].
- “Pre-Disease” Photographs: Bring several high-quality photos of your face from before your eyes changed. Close-up photos that show your eyelid position and the “sparkle” in your eyes help the doctor establish your personal baseline [17][18].
- Symptom Timeline: Write down exactly when you first noticed changes—even if they were subtle—and whether they fluctuate throughout the day [17][19].
Long-Term Monitoring
Because EGO can be a “prelude” to thyroid issues, your care doesn’t end when your eyes stabilize. Your team will develop an individualized plan to check your thyroid function (TSH and Free T4) periodically. Seek earlier testing if you develop symptoms like a racing heart, anxiety, or unexplained weight loss [20][8]. Continuing this surveillance for several years is standard practice, as thyroid dysfunction can emerge long after the eye symptoms begin [9][2].
Common questions in this guide
Which specialists should be involved in euthyroid Graves orbitopathy care?
Can euthyroid Graves orbitopathy occur when thyroid blood tests are normal?
What should I bring to my first thyroid eye disease appointment?
What does a negative TRAb or TBII test mean if eye symptoms continue?
How will my doctor track whether the eye disease is changing?
Will I need thyroid testing after my eye symptoms stabilize?
Get notified when new evidence is published on Euthyroid Graves orbitopathy.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (20)
- 1
Prevalence of hyperthyroidism, hypothyroidism, and euthyroidism in thyroid eye disease: a systematic review of the literature.
Muñoz-Ortiz J, Sierra-Cote MC, Zapata-Bravo E, et al.
Systematic reviews 2020; (9(1)):201 doi:10.1186/s13643-020-01459-7.
PMID: 32873324 - 2
Euthyroid graves' ophthalmopathy in a Chinese population: A cross-sectional follow-up study.
Lai KK, Ali Abdulla Aljufairi FM, Sebastian JU, et al.
European journal of ophthalmology 2024; (34(5)):1432-1437 doi:10.1177/11206721241229470.
PMID: 38444235 - 3
A survey of current practices by the British Oculoplastic Surgery Society (BOPSS) and recommendations for delivering a sustainable multidisciplinary approach to thyroid eye disease in the United Kingdom.
Lee V, Avari P, Williams B, et al.
Eye (London, England) 2020; (34(9)):1662-1671 doi:10.1038/s41433-019-0664-z.
PMID: 31836832 - 4
2022 Update on Clinical Management of Graves Disease and Thyroid Eye Disease.
Hoang TD, Stocker DJ, Chou EL, Burch HB
Endocrinology and metabolism clinics of North America 2022; (51(2)):287-304 doi:10.1016/j.ecl.2021.12.004.
PMID: 35662442 - 5
Orbital disease in neuro-ophthalmology.
Dohlman JC, Cestari DM, Freitag SK
Current opinion in ophthalmology 2020; (31(6)):469-474 doi:10.1097/ICU.0000000000000699.
PMID: 33009078 - 6
Medical and surgical treatment of thyroid eye disease.
Hall AJH, Topliss DJ
Internal medicine journal 2022; (52(1)):14-20 doi:10.1111/imj.15067.
PMID: 32975863 - 7
Clinical course of thyroid function and thyroid associated-ophthalmopathy in patients with euthyroid Graves' disease.
Suzuki N, Noh JY, Kameda T, et al.
Clinical ophthalmology (Auckland, N.Z.) 2018; (12()):739-746 doi:10.2147/OPTH.S158967.
PMID: 29719374 - 8
Thyroid antibody-negative euthyroid Graves' ophthalmopathy.
Tabasum A, Khan I, Taylor P, et al.
Endocrinology, diabetes & metabolism case reports 2016; (2016()):160008 doi:10.1530/EDM-16-0008.
PMID: 27284451 - 9
A systematic review of euthyroid Graves' disease (Review).
Macovei ML, Azis Ű, Gheorghe AG, Burcea M
Experimental and therapeutic medicine 2021; (22(5)):1346 doi:10.3892/etm.2021.10781.
PMID: 34630700 - 10
Management of Thyroid Eye Disease-Related Strabismus.
Akbari MR, Mirmohammadsadeghi A, Mahmoudzadeh R, Veisi A
Journal of current ophthalmology 2020; (32(1)):1-13 doi:10.1016/j.joco.2019.10.002.
PMID: 32510007 - 11
Euthyroid Graves' Ophthalmopathy With Negative Antibodies (EGONA): A Comprehensive Case-Based Review.
Bonny M, Wehbe M, Zaydan R, et al.
Cureus 2025; (17(12)):e100152 doi:10.7759/cureus.100152.
PMID: 41602258 - 12
Grading Severity and Activity in Thyroid Eye Disease.
Dolman PJ
Ophthalmic plastic and reconstructive surgery 2018; (34(4S Suppl 1)):S34-S40 doi:10.1097/IOP.0000000000001150.
PMID: 29952931 - 13
Establishing the usefulness of the GO-QOL in a UK hospital-treated population with thyroid eye disease in the CIRTED trial.
Dietrich A, Taylor P, White P, et al.
Psychology, health & medicine 2018; (23(sup1)):1341-1355 doi:10.1080/13548506.2018.1503693.
PMID: 30092670 - 14
Low clinical activity score, 'progressive' thyroid eye disease: presentations of 1439 patients from a tertiary centre in Hong Kong.
Lai KKH, Aljufairi FMAA, Sebastian JU, et al.
The British journal of ophthalmology 2025; (109(6)):715-720 doi:10.1136/bjo-2024-325346.
PMID: 39798945 - 15
Management of graves myopathy: Orbital imaging in thyroid-related orbitopathy.
Lo C, Ugradar S, Rootman D
Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus 2018; (22(4)):256.e1-256.e9 doi:10.1016/j.jaapos.2018.06.002.
PMID: 30055270 - 16
Computed tomography and magnetic resonance imaging approaches to Graves' ophthalmopathy: a narrative review.
Luccas R, Riguetto CM, Alves M, et al.
Frontiers in endocrinology 2023; (14()):1277961 doi:10.3389/fendo.2023.1277961.
PMID: 38260158 - 17
Management of thyroid eye disease in the United Kingdom: A multi-centre thyroid eye disease audit.
Mellington FE, Dayan CM, Dickinson AJ, et al.
Orbit (Amsterdam, Netherlands) 2017; (36(3)):159-169 doi:10.1080/01676830.2017.1280057.
PMID: 28296512 - 18
Evaluation of clinical and ocular surface changes in thyroid eye disease: impact of treatment and risk factors.
Barman Kakil Ş, Arslan N
Therapeutic advances in ophthalmology 2025; (17()):25158414251393119 doi:10.1177/25158414251393119.
PMID: 41322343 - 19
The Role of Thermal Camera in the Assessment of Thyroid Eye Disease Activity.
Prpic A, Kasumovic A, Guarro IG, et al.
Acta informatica medica : AIM : journal of the Society for Medical Informatics of Bosnia & Herzegovina : casopis Drustva za medicinsku informatiku BiH 2023; (31(4)):260-264 doi:10.5455/aim.2023.31.260-264.
PMID: 38379681 - 20
Hyperthyroidism: A Review.
Lee SY, Pearce EN
JAMA 2023; (330(15)):1472-1483 doi:10.1001/jama.2023.19052.
PMID: 37847271
This page is for informational purposes only and does not constitute medical advice. Your eye specialist and endocrinologist can tailor testing, monitoring, and treatment to your situation.